From our friends at DHD#10
February 18, 2022 – The U.S. Food and Drug Administration (FDA) has announced a food recall on some nutritional formula manufactured by Abbott in Sturgis, Michigan, due to consumer complaints of Cronobacter sakazakii and Salmonella Newport infections in infants after consumption.
Specifically, The FDA is advising consumers NOT USE the Similac brand POWDER formulas including Alimentum and EleCare infant formulas if:
To determine whether your formula has been affected by this recall, use the following link: https://www.similacrecall.com/us/en/home.html.
The following formulas NOT subject to this recall are: Isomil, Neosure, and the liquid concentrated and ready-to-feed Similac products.
Products that do not contain the information listed above are not impacted. The FDA advisory does not include liquid concentrated or ready-to-feed formula products or any metabolic deficiency nutrition formulas. Consumers should continue to use all products not covered by the advisory.
The FDA is investigating complaints of four infant illnesses from three states. All four cases related to these complaints were hospitalized and Cronobacter may have contributed to a death in one case. The FDA has initiated an onsite inspection at the facility. Findings to date include several positive Cronobacter sakazakii results from environmental samples taken by the FDA and adverse inspectional observations by the FDA investigators. A review of the firm’s internal records also indicate environmental contamination with Cronobacter sakazakii and the firm’s destruction of product due to the presence of Cronobacter.
District Health Department #10 (DHD#10) currently has over 1,100 clients within their Women, Infants, and Children (WIC) program that could be impacted by this recall.
“We are working very closely with State WIC Program officials to resolve this emergent situation,” stated Anne M. Bianchi, DHD#10 WIC Program Director. “DHD#10 staff is currently assisting clients to locate alternative formulas and resources until a state-wide solution is put in place.”
Until further notice, please consider the following guidance:
The FDA is continuing to investigate and will provide additional consumer safety information when it becomes available.
For Abbott’s press release, please follow this link: https://abbott.mediaroom.com/2022-02-17-Abbott-Voluntarily-Recalls-Powder-Formulas-Manufactured-at-One-Plant.
Your comment will be posted after it is approved.
Leave a Reply.